Literature DB >> 33547295

IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice.

Qingxiao Song1,2,3, Xiaoning Wang1,2,4, Xiwei Wu5, Tae Hyuk Kang5, Hanjun Qin5, Dongchang Zhao6, Robert R Jenq7, Marcel R M van den Brink8, Arthur D Riggs1, Paul J Martin9, Yuan-Zhong Chen10, Defu Zeng11,12.   

Abstract

Efforts to improve the prognosis of steroid-resistant gut acute graft-versus-host-disease (SR-Gut-aGVHD) have suffered from poor understanding of its pathogenesis. Here we show that the pathogenesis of SR-Gut-aGVHD is associated with reduction of IFN-γ+ Th/Tc1 cells and preferential expansion of IL-17-IL-22+ Th/Tc22 cells. The IL-22 from Th/Tc22 cells causes dysbiosis in a Reg3γ-dependent manner. Transplantation of IFN-γ-deficient donor CD8+ T cells in the absence of CD4+ T cells produces a phenocopy of SR-Gut-aGVHD. IFN-γ deficiency in donor CD8+ T cells also leads to a PD-1-dependent depletion of intestinal protective CX3CR1hi mononuclear phagocytes (MNP), which also augments expansion of Tc22 cells. Supporting the dual regulation, simultaneous dysbiosis induction and depletion of CX3CR1hi MNP results in full-blown Gut-aGVHD. Our results thus provide insights into SR-Gut-aGVHD pathogenesis and suggest the potential efficacy of IL-22 antagonists and IFN-γ agonists in SR-Gut-aGVHD therapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33547295      PMCID: PMC7865028          DOI: 10.1038/s41467-021-21133-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  61 in total

1.  CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice.

Authors:  Oscar Medina-Contreras; Duke Geem; Oskar Laur; Ifor R Williams; Sergio A Lira; Asma Nusrat; Charles A Parkos; Timothy L Denning
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

2.  CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.

Authors:  Brian C Betts; Elizabeth M Sagatys; Anandharaman Veerapathran; Mark C Lloyd; Francisca Beato; Harshani R Lawrence; Binglin Yue; Jongphil Kim; Said M Sebti; Claudio Anasetti; Joseph Pidala
Journal:  J Leukoc Biol       Date:  2015-02-06       Impact factor: 4.962

Review 3.  Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-11-30       Impact factor: 91.245

4.  T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage.

Authors:  S Takashima; M L Martin; S A Jansen; Y Fu; J Bos; D Chandra; M H O'Connor; A M Mertelsmann; P Vinci; J Kuttiyara; S M Devlin; S Middendorp; M Calafiore; A Egorova; M Kleppe; Y Lo; N F Shroyer; E H Cheng; R L Levine; C Liu; R Kolesnick; C A Lindemans; A M Hanash
Journal:  Sci Immunol       Date:  2019-12-06

Review 5.  Secondary treatment of acute graft-versus-host disease: a critical review.

Authors:  Paul J Martin; Yoshihiro Inamoto; Mary E D Flowers; Paul A Carpenter
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-14       Impact factor: 5.742

Review 6.  Next generation treatment of acute graft-versus-host disease.

Authors:  J Magenau; P Reddy
Journal:  Leukemia       Date:  2014-06-18       Impact factor: 11.528

7.  Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria.

Authors:  Rajatava Basu; Darrell B O'Quinn; Daniel J Silberger; Trenton R Schoeb; Lynette Fouser; Wenjun Ouyang; Robin D Hatton; Casey T Weaver
Journal:  Immunity       Date:  2012-11-29       Impact factor: 31.745

8.  Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Authors:  Tangsheng Yi; Dongchang Zhao; Chia-Lei Lin; Chunyan Zhang; Ying Chen; Ivan Todorov; Thomas LeBon; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

9.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

10.  The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine.

Authors:  Shipra Vaishnava; Miwako Yamamoto; Kari M Severson; Kelly A Ruhn; Xiaofei Yu; Omry Koren; Ruth Ley; Edward K Wakeland; Lora V Hooper
Journal:  Science       Date:  2011-10-14       Impact factor: 47.728

View more
  7 in total

Review 1.  Acute GVHD: think before you treat.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets.

Authors:  Liyun Ma; Jianghong Yu; Huilu Zhang; Bing Zhao; Jun Zhang; Dongqin Yang; Feifei Luo; Bangting Wang; Bohan Jin; Jie Liu
Journal:  Stem Cell Rev Rep       Date:  2022-03-12       Impact factor: 6.692

Review 3.  Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model.

Authors:  Qingxiao Song; Ubaydah Nasri; Defu Zeng
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

Review 4.  The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation.

Authors:  Lam T Khuat; Maneesh Dave; William J Murphy
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 5.  Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage.

Authors:  Takahide Ara; Daigo Hashimoto
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

6.  Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice.

Authors:  Pan Pan; Samantha N Atkinson; Brian Taylor; Haojie Zhu; Dian Zhou; Philip Flejsierowicz; Li-Shu Wang; Matthew Morse; Chen Liu; Ian L Gunsolus; Xiao Chen
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

7.  IL-12RB1: a novel immune prognostic biomarker for oral squamous cell carcinoma and linked to PD-1/PD-L1 expression in the tumor immune microenvironment.

Authors:  Zheng Chen; Qiang Chen; Shuai Li; Shaoqin Tu; Qiongyu Chen; Anxun Wang
Journal:  Ann Transl Med       Date:  2022-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.